It’s been more than three years since DBV Technologies’ peanuty allergy therapy was rejected for FDA approval, but the company thinks it now has a clear route to market with its patch product ...

Investing.com -- The US Food and Drug Administration (FDA) has approved Sanofi (NASDAQ:SNY)’s treatment for hemophilia, Qfitlia (fitusiran), which can be administered as infrequently as once ...

Novartis has claimed accelerated approval from the FDA for a second indication for Fabhalta – IgA nephropathy (IgAN) – as it charts a course to blockbuster sales for the drug. The US regulator ...

Fidia is listed on the Euronext Milan trading with ticker code FDA.MI. It has a market capitalisation of €58.31k, with approximately 8.33m shares in issue. Over the last year, Fidia share price ...